Clinical Trial Update: Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant [Phase 4]

View source ↗

Summary

Clinical trial update for a Phase 4 study evaluating atezolizumab and bevacizumab in combination with Y-90 radioembolization for hepatocellular carcinoma in the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: RECRUITING